Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

医学 指南 一致性 人表皮生长因子受体2 临床肿瘤学 乳腺癌 肿瘤科 内科学 癌症 妇科 病理 家庭医学
作者
Antonio C. Wolff,M. Elizabeth H. Hammond,David G. Hicks,Mitch Dowsett,Lisa M. McShane,Kimberly H. Allison,Donald Craig Allred,John M.S. Bartlett,Michael Bilous,Patrick L. Fitzgibbons,Wedad M. Hanna,Robert Brian Jenkins,Pamela B. Mangu,Soonmyung Paik,Edith A. Perez,Michael F. Press,Patricia A. Spears,Gail H. Vance,Giuseppe Viale,Daniel F. Hayes
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:31 (31): 3997-4013 被引量:4015
标识
DOI:10.1200/jco.2013.50.9984
摘要

PURPOSE: To update the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guideline recommendations for human epidermal growth factor receptor 2 (HER2) testing in breast cancer to improve the accuracy of HER2 testing and its utility as a predictive marker in invasive breast cancer. METHODS: ASCO/CAP convened an Update Committee that included coauthors of the 2007 guideline to conduct a systematic literature review and update recommendations for optimal HER2 testing. RESULTS: The Update Committee identified criteria and areas requiring clarification to improve the accuracy of HER2 testing by immunohistochemistry (IHC) or in situ hybridization (ISH). The guideline was reviewed and approved by both organizations. RECOMMENDATIONS: The Update Committee recommends that HER2 status (HER2 negative or positive) be determined in all patients with invasive (early stage or recurrence) breast cancer on the basis of one or more HER2 test results (negative, equivocal, or positive). Testing criteria define HER2-positive status when (on observing within an area of tumor that amounts to > 10% of contiguous and homogeneous tumor cells) there is evidence of protein overexpression (IHC) or gene amplification (HER2 copy number or HER2/CEP17 ratio by ISH based on counting at least 20 cells within the area). If results are equivocal (revised criteria), reflex testing should be performed using an alternative assay (IHC or ISH). Repeat testing should be considered if results seem discordant with other histopathologic findings. Laboratories should demonstrate high concordance with a validated HER2 test on a sufficiently large and representative set of specimens. Testing must be performed in a laboratory accredited by CAP or another accrediting entity. The Update Committee urges providers and health systems to cooperate to ensure the highest quality testing. This guideline was developed through a collaboration between the American Society of Clinical Oncology and the College of American Pathologists and has been published jointly by invitation and consent in both Journal of Clinical Oncology and the Archives of Pathology & Laboratory Medicine.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
lhm完成签到 ,获得积分10
1秒前
2秒前
无花果的应助被zy采纳,获得10
2秒前
xiaoX12138发布了新的文献求助10
2秒前
精明依云发布了新的文献求助10
3秒前
专一的弱完成签到,获得积分10
3秒前
3秒前
希望天下0贩的0的应助被Johnny采纳,获得10
3秒前
4秒前
Heven88发布了新的文献求助10
4秒前
4秒前
4秒前
4秒前
风中小丸子完成签到,获得积分10
4秒前
5秒前
可爱的函函的应助被paopao采纳,获得10
5秒前
5秒前
molihuakai的应助被ZZXX采纳,获得10
5秒前
Aurora完成签到 ,获得积分10
5秒前
小队昵称完成签到,获得积分10
6秒前
伽玛伽玛完成签到 ,获得积分10
7秒前
starcraftfan完成签到,获得积分10
8秒前
8秒前
xdy发布了新的文献求助10
8秒前
Walker完成签到,获得积分10
8秒前
星空完成签到,获得积分10
8秒前
贾贡献的应助被诚心的万宝路采纳,获得10
8秒前
rslysywd发布了新的文献求助10
8秒前
大气的杨完成签到 ,获得积分10
9秒前
雨文发布了新的文献求助10
9秒前
oooaaa发布了新的文献求助10
10秒前
精明依云发布了新的文献求助10
11秒前
大君完成签到,获得积分10
13秒前
百步穿小杨完成签到,获得积分10
13秒前
13秒前
13秒前
阿金发布了新的文献求助10
13秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181892
求助须知:如何正确求助?哪些是违规求助? 9571628
关于积分的说明 21818984
捐赠科研通 7778258
什么是DOI,文献DOI怎么找? 3433556
关于科研通互助平台的介绍 2557720
邀请新用户注册赠送积分活动 2479621